{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:01:07Z","timestamp":1780124467355,"version":"3.54.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mustela Foundation","award":["Grant\/prize for research in pediatric dermatology"],"award-info":[{"award-number":["Grant\/prize for research in pediatric dermatology"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mastocytosis is a disorder characterized by abnormal mast cell proliferation, leading to cutaneous mastocytosis (CM) or systemic mastocytosis (SM) when internal organs are affected. While adult mastocytosis is associated with osteoporosis, data on bone mineral density (BMD) in children are lacking. To our knowledge, this is one of the first studies investigating BMD in pediatric mastocytosis. We conducted a prospective cross-sectional study including clinical and laboratory data from a database (2004-2025), covering mastocystosis subtype, serum tryptase, and c-kit mutation status. BMD was measured in children aged 4-18 years using dual-energy X-ray absorptiometry (DEXA) at the lumbar spine and total body. 76 children were included (73 CM, 3 SM [ISM]). Low BMD (Z-score \u2264 \u20132) was observed in 6.8% of CM patients, significantly more prevalent than in the general pediatric population (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.0014). However, all normalized spontaneously during follow-up. None had osteoporosis. ISM patients had significantly higher tryptase levels but normal BMD. BMD was not correlated with disease specific characteristics, bone pain or fractures.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Our findings suggest that bone involvement is not a major concern in pediatric mastocytosis. DEXA scans could potentially be reserved for children with suspected systemic involvement. Future longitudinal studies are necessary to further elucidate bone involvement in these patients.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\" colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\u00a0\n                              <jats:italic>Mastocytosis is a rare disorder, associated with osteoporosis and fractures in adults. Data on bone density in the pediatric population are lacking.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\" colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Our results suggest that bone involvement is not a major concern in pediatric mastocytosis.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-06953-z","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:25:15Z","timestamp":1777497915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low BMD is uncommon in pediatric mastocytosis: a DEXA- based cohort study"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2123-8233","authenticated-orcid":false,"given":"Antje","family":"Geypen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Jhinkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-4475","authenticated-orcid":false,"given":"Suzanne G. M. A.","family":"Pasmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1967-6476","authenticated-orcid":false,"given":"Nicolette J. T.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"1","key":"6953_CR1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2021.069","volume":"13","author":"F Giona","year":"2021","unstructured":"Giona F (2021) Pediatric mastocytosis: an update. Mediterr J Hematol Infect Dis 13(1):e2021069","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"6953_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11882-017-0748-4","volume":"17","author":"N Klaiber","year":"2017","unstructured":"Klaiber N, Kumar S, Irani AM (2017) Mastocytosis in children. Curr Allergy Asthma Rep 17(11):80","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"6953_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","volume":"137","author":"K Hartmann","year":"2016","unstructured":"Hartmann K et al (2016) Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol 137(1):35\u201345","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"6953_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u2013405","journal-title":"Blood"},{"issue":"1","key":"6953_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10654-024-01195-5","volume":"40","author":"MP J\u00f8rgensen","year":"2025","unstructured":"J\u00f8rgensen MP et al (2025) Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study. Eur J Epidemiol 40(1):43\u201353","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"6953_CR6","first-page":"159","volume":"3","author":"P Valent","year":"2013","unstructured":"Valent P (2013) Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology. Am J Cancer Res 3(2):159\u2013172","journal-title":"Am J Cancer Res"},{"issue":"11","key":"6953_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD (2017) Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood 129(11):1420\u20131427","journal-title":"Blood"},{"issue":"9","key":"6953_CR8","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/ced.15262","volume":"47","author":"MAW Hermans","year":"2022","unstructured":"Hermans MAW et al (2022) Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children. Clin Exp Dermatol 47(9):1694\u20131702","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"6953_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40257-020-00581-5","volume":"22","author":"JV Schaffer","year":"2021","unstructured":"Schaffer JV (2021) Pediatric mastocytosis: recognition and management. Am J Clin Dermatol 22(2):205\u2013220","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"6953_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ajh.25371","volume":"94","author":"A Pardanani","year":"2019","unstructured":"Pardanani A (2019) Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol 94(3):363\u2013377","journal-title":"Am J Hematol"},{"issue":"23","key":"6953_CR11","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH et al (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113(23):5727\u201336","journal-title":"Blood"},{"key":"6953_CR12","unstructured":"(NVK), N.V.v.K (2023) Werkboek Kinderallergologie(3e druk, pp. 116\u2013121)\u00a0"},{"key":"6953_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052586","author":"M Lange","year":"2021","unstructured":"Lange M et al (2021) Molecular background, clinical features and management of pediatric mastocytosis: status 2021. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22052586","journal-title":"Int J Mol Sci"},{"key":"6953_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13233583","author":"H \u0141ugowska-Umer","year":"2023","unstructured":"\u0141ugowska-Umer H et al (2023) Current challenges in the diagnosis of pediatric cutaneous mastocytosis. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics13233583","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"6953_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/11588890-000000000-00000","volume":"12","author":"M Castells","year":"2011","unstructured":"Castells M, Metcalfe DD, Escribano L (2011) Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol 12(4):259\u2013270","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"6953_CR16","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.jaip.2019.05.032","volume":"7","author":"MM Liu","year":"2019","unstructured":"Liu MM et al (2019) Treatment of systemic mastocytosis in an infant with midostaurin. J Allergy Clin Immunol Pract 7(8):2929-2931.e1","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"6953_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.32129","volume":"73","author":"A Kiwit","year":"2026","unstructured":"Kiwit A et al (2026) Aggressive systemic mastocytosis related to germline p.D816V KIT mutation. Pediatr Blood Cancer 73(1):e32129","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"6953_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jaip.2022.12.016","volume":"11","author":"D Voelker","year":"2023","unstructured":"Voelker D et al (2023) Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin. J Allergy Clin Immunol Pract 11(4):1323-1325.e1","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"6953_CR19","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00198-016-3539-1","volume":"27","author":"M Rossini","year":"2016","unstructured":"Rossini M et al (2016) Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis. Osteoporos Int 27(8):2411\u201321","journal-title":"Osteoporos Int"},{"issue":"1","key":"6953_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1468-3083.2011.04365.x","volume":"27","author":"M Lange","year":"2013","unstructured":"Lange M et al (2013) Clinical aspects of paediatric mastocytosis: a review of 101 cases. J Eur Acad Dermatol Venereol 27(1):97\u2013102","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"6953_CR21","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1016\/j.jaip.2023.06.045","volume":"11","author":"IFA Bocca-Tjeertes","year":"2023","unstructured":"Bocca-Tjeertes IFA et al (2023) Vertebral fracture in a 7-year-old boy with indolent systemic mastocytosis. J Allergy Clin Immunol Pract 11(10):3269\u20133271","journal-title":"J Allergy Clin Immunol Pract"},{"key":"6953_CR22","unstructured":"Official pediatric positions: skeletal health assessment in children from infancy to adolescence (2019 ISCD Pediatric Official Positions) (2019) International Society for Clinical Densitometry"},{"issue":"1","key":"6953_CR23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3917\/jib.151.0124","volume":"15","author":"World Medical Association Declaration of Helsinki","year":"2004","unstructured":"World Medical Association Declaration of Helsinki (2004) ethical principles for medical research involving human subjects. J Int Bioethique 15(1):124\u2013129","journal-title":"J Int Bioethique"},{"issue":"2","key":"6953_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/ajcp\/aqaf008","volume":"164","author":"RC Shean","year":"2025","unstructured":"Shean RC et al (2025) High-sensitivity KIT D816V variation analysis by droplet digital polymerase chain reaction: the reference laboratory perspective. Am J Clin Pathol 164(2):145\u2013149","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"6953_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","volume":"13","author":"T Kristensen","year":"2011","unstructured":"Kristensen T, Vestergaard H, M\u00f8ller MB (2011) Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn 13(2):180\u2013188","journal-title":"J Mol Diagn"},{"key":"6953_CR26","unstructured":"Nederlandse Vereniging voor Allergologie en Klinische Immunologie (NVvAKI), e.a., Richtlijn Mastocytose. 2022"},{"issue":"11","key":"6953_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000646","volume":"5","author":"P Valent","year":"2021","unstructured":"Valent P et al (2021) Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. Hemasphere 5(11):e646","journal-title":"Hemasphere"},{"issue":"6","key":"6953_CR28","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1210\/jc.2006-2553","volume":"92","author":"HJ Kalkwarf","year":"2007","unstructured":"Kalkwarf HJ et al (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087\u201399","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6953_CR29","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1210\/jc.2010-0677","volume":"95","author":"J Kocks","year":"2010","unstructured":"Kocks J et al (2010) Z-score comparability of bone mineral density reference databases for children. J Clin Endocrinol Metab 95(10):4652\u20134659","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6953_CR30","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/ard.2009.124511","volume":"69","author":"S Barete","year":"2010","unstructured":"Barete S et al (2010) Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis 69(10):1838\u201341","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6953_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","volume":"49","author":"M Rossini","year":"2011","unstructured":"Rossini M et al (2011) Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 49(4):880\u20135","journal-title":"Bone"},{"issue":"2","key":"6953_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1359\/jbmr.071010","volume":"23","author":"EM Clark","year":"2008","unstructured":"Clark EM, Ness AR, Tobias JH (2008) Bone fragility contributes to the risk of fracture in children, even after moderate and severe trauma. J Bone Miner Res 23(2):173\u2013179","journal-title":"J Bone Miner Res"},{"issue":"7","key":"6953_CR33","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1210\/jc.2010-2546","volume":"96","author":"AM Boyce","year":"2011","unstructured":"Boyce AM, Gafni RI (2011) Approach to the child with fractures. J Clin Endocrinol Metab 96(7):1943\u20131952","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"6953_CR34","doi-asserted-by":"publisher","first-page":"e3887","DOI":"10.1210\/clinem\/dgac323","volume":"107","author":"HJ Kalkwarf","year":"2022","unstructured":"Kalkwarf HJ et al (2022) Reference ranges for bone mineral content and density by dual energy x-ray absorptiometry for young children. J Clin Endocrinol Metab 107(9):e3887\u2013e3900","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6953_CR35","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96(10):3160\u20133169","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6953_CR36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00198-019-04918-7","volume":"30","author":"Y Degbo\u00e9","year":"2019","unstructured":"Degbo\u00e9 Y et al (2019) Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome. Osteoporos Int 30(6):1235\u20131241","journal-title":"Osteoporos Int"},{"issue":"3","key":"6953_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1398-9995.2011.02780.x","volume":"67","author":"E van der Veer","year":"2012","unstructured":"van der Veer E et al (2012) High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. Allergy 67(3):431\u20138","journal-title":"Allergy"},{"issue":"5","key":"6953_CR38","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2340\/00015555-2325","volume":"96","author":"S Broesby-Olsen","year":"2016","unstructured":"Broesby-Olsen S et al (2016) Multidisciplinary management of mastocytosis: Nordic Expert Group consensus. Acta Derm Venereol 96(5):602\u201312","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"6953_CR39","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jaip.2024.02.021","volume":"12","author":"Y Degbo\u00e9","year":"2024","unstructured":"Degbo\u00e9 Y et al (2024) The prevalence of osteoporosis is low in adult cutaneous mastocytosis patients. J Allergy Clin Immunol Pract 12(5):1306\u20131312","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"6953_CR40","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1016\/j.jaip.2021.08.001","volume":"9","author":"A Makovoz","year":"2021","unstructured":"Makovoz A et al (2021) Assessment of osteoporosis and fracture risk in mastocytosis within a North American cohort. J Allergy Clin Immunol Pract 9(12):4459-4467.e10","journal-title":"J Allergy Clin Immunol Pract"},{"key":"6953_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246380","author":"R Zanotti","year":"2021","unstructured":"Zanotti R et al (2021) A multidisciplinary diagnostic approach reveals a higher prevalence of indolent systemic mastocytosis: 15-years\u2019 experience of the GISM network. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13246380","journal-title":"Cancers (Basel)"},{"issue":"2","key":"6953_CR42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000059404","volume":"128","author":"WR Sperr","year":"2002","unstructured":"Sperr WR et al (2002) Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol 128(2):136\u201341","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"6953_CR43","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","volume":"136","author":"MC Carter","year":"2015","unstructured":"Carter MC et al (2015) Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis. J Allergy Clin Immunol 136(6):1673-1679.e3","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"6953_CR44","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","volume":"67","author":"I Alvarez-Twose","year":"2012","unstructured":"Alvarez-Twose I et al (2012) Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy 67(6):813\u201321","journal-title":"Allergy"},{"issue":"2","key":"6953_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini M et al (2014) Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin North Am 34(2):383\u201396","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"6953_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11914-025-00901-w","volume":"23","author":"Y Degbo\u00e9","year":"2025","unstructured":"Degbo\u00e9 Y et al (2025) Management of bone health in adult mastocytosis. Curr Osteoporos Rep 23(1):10","journal-title":"Curr Osteoporos Rep"},{"key":"6953_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1182\/asheducation-2015.1.98","volume":"2015","author":"P Valent","year":"2015","unstructured":"Valent P (2015) Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Hematology Am Soc Hematol Educ Program 2015:98\u2013105","journal-title":"Hematol Am Soc Hematol Educ Program"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06953-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:02:01Z","timestamp":1780120921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06953-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6953"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06953-z","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}